Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


Allergies 2014

09 Jul 2014 - 10 Jul 2014 - London, UK



Bookmark and Share


Analyse industry developments and the future of allergy therapeutics

The launch event for Allergies is here and will be taking place on 9th July and 10th July 2014 in Central London. The market for Allergies is expected to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, this event will mark the path forward in terms of allergies within personalised medicines and beyond.

We have worked in partnership with an expert advisory board which includes KOLs from Imperial College London, Swecure AB and GSK, to put together an exciting conference agenda.

The programme will examine key areas such as novel approaches in the treatment of allergy, therapeutic advances, allergic pathophysiology, current update on food allergies, the future of allergen-specific immunotherapy and challenges, allergy prevention, diagnosis and drug development plus much more. 

Reasons to Attend:

  • Key case study presentation from GSK on new therapeutic tools for allergies
  • Clinicians' perspective – advances in allergy diagnostics featuring Royal Free Hospital and Imperial College London
  • Allergy specialists – Dr Scadding and Dr Church present on new research and findings
  • Exclusive case study on the success of peanut allergy trials
  • Evaluate new breakthroughs in allergy treatment and gain understanding into guidance on development novel therapeutics
  • Analyse current and novel approaches of allergen-specific immunotherapy 

Key Speakers Include:

  • Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
  • Professor Alf Lindberg, Chief Scientific Director, Swecure AB
  • Dr Rainer Henning, CEO, Biomay AG
  • Dr Donna Finch, Principal Scientist, MedImmune
  • Dr Glenis Scadding, Honorary Consultant Allergist & Rhinologist, Royal National Throat, Nose and Ear Hospital
  • Calman Prussin, Principal Investigator, National Institute of Allergy and Infectious Diseases(NIAID)
  • Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna

To register online or to download a brochure visit http://www.smi-online.co.uk/goto/allergies7.asp

Alternatively contact John Collins on +44 (0)20 7827 6734 or email jcollins@smi-online.co.uk




Further information
Scientific News
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
Researchers Discover New Type of Mycovirus
Virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!